3 completed. 3 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 1 | 1 | Completed 1 |
Follow Renal Disease: new trials by email Literature Review of Renal Disease trials Research Report on Renal Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of Viusid and Asbrip in Hospitalized Patients Infected by SARS-Cov-2 With COVID-19 Viusid and Asbrip - Covid-19, Sars-CoV2 | Phase 2 | Completed | Catalysis SL | 60 | 2020-05-04 | 2021-01-08 |
| Efficacy and Safety of Renalof® in the Removal of Calculi Smaller Than 10 mm Located in the Reno-Ureteral Tract Renalof, Placebo - Renal Injury, Kidney Injury | Phase 2 | Completed | Catalysis SL | 155 | 2019-08-01 | 2021-01-06 |
| Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation IdeS® (Imlifidase) - Renal Disease | Phase 1 / Phase 2 | Completed | Cedars-Sinai Medical Center | 17 | 2015-06-16 | 2022-05-16 |
Kidney Diseases (3) · COVID-19 (1) · Diabetes Mellitus (1) · Heart Diseases (1) · Kidney Calculi (1) · Kidney Failure, Chronic (1) · Liver Diseases (1) · Lung Diseases (1) · Nephrolithiasis (1) · Nephrolithiasis, Calcium Oxalate (1) · Ureteral Calculi (1) · Ureteral Obstruction (1) · Urolithiasis (1)
Female Urogenital Diseases (3) · Female Urogenital Diseases and Pregnancy Complications (3) · Male Urogenital Diseases (3) · Urogenital Diseases (3) · Urologic Diseases (3) · Pathological Conditions, Signs and Symptoms (2) · Calculi (1) · Cardiovascular Diseases (1) · Chronic Disease (1) · Coronaviridae Infections (1) · Coronavirus Infections (1) · Digestive System Diseases (1) · Disease Attributes (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1)
Viusid (1)
Catalysis SL (2) · Cedars-Sinai Medical Center (1)
Ecuador (1) · Nicaragua (1) · United States (1)